These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29064182)

  • 21. New oral anticoagulants for atrial fibrillation: a review of clinical trials.
    O'Dell KM; Igawa D; Hsin J
    Clin Ther; 2012 Apr; 34(4):894-901. PubMed ID: 22417716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.
    McCullough PA; Ball T; Cox KM; Assar MD
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2079-2084. PubMed ID: 27797888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
    Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
    Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New oral anticoagulants in patients with chronic kidney disease.
    Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
    Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic Kidney Disease as Basis of High Thrombotic and Bleeding Risk in Patients With Atrial Fibrillation: Place of Oral Anticoagulants].
    Obrezan AG; Zemchenkov AY
    Kardiologiia; 2018 Apr; (4):60-70. PubMed ID: 29782261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct oral anticoagulants in chronic kidney disease: an update.
    Mavrakanas TA; Charytan DM; Winkelmayer WC
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):489-496. PubMed ID: 32740218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population.
    Amin A; Keshishian A; Trocio J; Dina O; Le H; Rosenblatt L; Liu X; Mardekian J; Zhang Q; Baser O; Vo L
    Curr Med Res Opin; 2017 Sep; 33(9):1595-1604. PubMed ID: 28635338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.
    Franczyk B; Gluba-Brzózka A; Ciałkowska-Rysz A; Banach M; Rysz J
    Curr Vasc Pharmacol; 2016; 14(3):260-5. PubMed ID: 26769703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
    Stamellou E; Floege J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.
    Ravera M; Bussalino E; Fusaro M; Di Lullo L; Aucella F; Paoletti E
    J Nephrol; 2020 Jun; 33(3):483-495. PubMed ID: 32200488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulants in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Ingram AJ; Herzog CA
    Nat Rev Nephrol; 2012 Oct; 8(10):569-78. PubMed ID: 22825670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of safety and efficacy for direct oral anticoagulation treatment of non-valvular atrial fibrillation in relation to renal function.
    Zou R; Tao J; Shi W; Yang M; Li H; Lin X; Yang S; Hua P
    Thromb Res; 2017 Dec; 160():41-50. PubMed ID: 29096154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
    Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
    Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure.
    Cortese F; Scicchitano P; Gesualdo M; Ricci G; Carbonara S; Franchini C; Pia Schiavone BI; Corbo F; Ciccone MM
    Curr Med Chem; 2017 Nov; 24(34):3813-3827. PubMed ID: 28820069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
    Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.